Related Experiment Video
Updated: Jun 17, 2025
06:45
Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
Published on: October 4, 2021
2.7K
Dopa-responsive Rest Tremor Preceding Tachyphemia in Progressive Supranuclear Palsy
Takuro Shiga1, Shun Ishiyama1, Naoto Sugeno1
1Department of Neurology, Tohoku University Graduate School of Medicine, Japan.
Internal Medicine (Tokyo, Japan)
|August 13, 2024
Summary
This case study highlights a unique presentation of Progressive Supranuclear Palsy (PSP), featuring early dopa-responsive tremor and later speech issues. The findings expand understanding of the diverse clinical spectrum of this rare neurological disorder.
Area of Science:
- Neurology
- Neurodegenerative Diseases
Background:
- Progressive Supranuclear Palsy (PSP) is a rare neurodegenerative disorder.
- Key features include postural instability, falls, and vertical gaze palsy.
Purpose of the Study:
- To present a unique case of probable Progressive Supranuclear Palsy with atypical initial symptoms.
- To illustrate the broad clinical spectrum of PSP syndrome.
Main Methods:
- Case report of a 71-year-old woman.
- Clinical evaluation based on diagnostic criteria for PSP.
Main Results:
- The patient presented with dopa-responsive rest tremor and slowness, followed by tachyphemia (speech difficulty) and postural instability.
- Diagnosis of probable PSP-RS was made based on clinical presentation.
Conclusions:
- The observed clinical manifestations are unique and contribute to understanding the variability of PSP.
- This case underscores the importance of recognizing diverse presentations for accurate PSP diagnosis.
Related Concept Videos
01:24Parkinson's Disease: Treatment
241
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
241
01:15Parkinson's Disease: Overview
508
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
508
01:29Drugs Affecting Neurotransmitter Synthesis
1.3K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.3K
01:28Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
290
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
290
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
240
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
240
01:15REM Sleep Behavior Disorder
167
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
167